TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Denmark ,Texas ,United States ,Hellerup ,Hovedstaden ,Gwendolyn Schanker ,Rasmus Toft Kehler ,Corey Davis ,Michael Saag ,Safety Management Committee ,School Of Medicine ,Drug Administration ,Nasdaq ,Film Freezing Technology Platform ,Lifesci Communications ,Pharmaceuticals Scientific Advisory Board ,Pharmaceuticals Inc ,Inhaled Niclosamide Estimated ,Produce Concentrations ,Complete Phase ,Pharmacokinetic Data ,Inhaled Niclosamide ,Thin Film Freezing ,Scientific Advisory ,Glenn Mattes ,Chief Operating Officer ,Single Ascending Dose ,Multiple Ascending Dose ,Thin Film Freezing Technology Platform ,Matrix Particle ,Voriconazole Inhalation Powder ,Tacrolimus Inhalation ,Relations Contact ,Coronavirus Pandemic ,Technology ,Science ,Health ,Business ,Globe Newswire ,Patents ,